COMPANY PROFILE

Resurrect Bio

Explore full profile

AI-driven gene editing for crop disease resistance.

London, United KingdomFounded 2021Food

Valuation $25–50M Last recorded · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Resurrect Bio

Resurrect Bio is a UK agricultural biotechnology company spun out of The Sainsbury Laboratory in 2021 by Professor Sophien Kamoun, Professor Tolga Bozkurt and CEO Dr Cian Duggan. Its platform uses FloraFold AI to map how pathogen proteins disable plant immune receptors, then applies precise gene editing to restore native R-genes without foreign DNA—speeding disease-resistance traits for soy, corn and wheat versus conventional breeding. The B2B model licenses traits to seed companies via fees, milestones and royalties; in March 2026 it announced a joint development agreement with Corteva for U.S. corn diseases. After a 2023 £1.61 million ($2.1 million) seed, Resurrect Bio announced an initial Series A close of $8.1 million in February 2026 led by Corteva Catalyst with Calculus Capital, Pymwymic and AgFunder, to scale trait discovery and advance commercial partnerships. Sources: company / AgFunder coverage Feb 2026; resurrect.bio.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: London, United Kingdom
Employees: 20
Open positions: None listed
Dealroom signal: 88.4/100
Sub-industry: AgriTech
Sector: Food, Biotechnology, Crop Protection, Core AI, Spinout, Sustainable Development Goals, Biotechnology in Food, Climate Tech, DT and LS
Technology: Artificial Intelligence, Deep Tech
Business model: Manufacturing
Client focus: b2b, b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	May 2026	$2.2M	$41M	AgFunder · Future Planet Capital · Calculus Capital · Pymwymic	↗
SERIES AOther financing	Feb 2026	$8.1M	$32M	Calculus Capital · Corteva · AgFunder · Pymwymic	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Resurrect Bio website traffic

Latest recorded traffic for Resurrect Bio is 1.4K monthly website visits, down 57.6% over the last three months. Resurrect Bio's team grew 66.7% over the past year.

Latest monthly visits1.4K 3-month web change-57.6% 1-year team growth+66.7%

Monthly website visitsMay 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
WBWild BioscienceSustainably enhanced crops for a wilder future	Oxford, United Kingdom	Operational	43	$63M	$240M
SBSOLASTA BioNature-inspired, peptide-based bioinsecticides for targeted pest control	Glasgow, United Kingdom	Operational
BIBiocentisGenetic insect control solutions for agriculture and health	London, United Kingdom	Operational
SUSugaroxSugaROx uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production	St Albans, United Kingdom	Operational
CRCroBioMicrobial technology enhancing soil water retention, drought resilience	Alderley Edge, United Kingdom	Operational
OXOxitecGenetically engineered insects for biological pest control	Milton, United Kingdom	Acquired
BIBionemaBiocontrol technology developing natural microbial pest management solutions	Sarratt, United Kingdom	Operational
BABactobioLondon-based biotechnology company using breakthrough technologies in synthetic biology	London, United Kingdom	Operational